# Investigation Methodology — Oath Peptides Scam > How this Oath Peptides scam investigation was conducted: the five-layer dismantle framework, the public sources examined, the verification paths, and the editorial bounds the case file owns. The framework, the sources, the verification paths, and the editorial bounds this case file owns in the open. ## Scope This case file investigates the Oath Peptides scam claim as it appears in the public record — that is, claims that are publishable, indexable, and findable through standard search workflows on the brand-plus-modifier query class. It does not investigate Oath's internal operations, its private financial records, its supplier contracts, or its order-fulfillment systems. Where the investigation would require non-public information, the bound is named in the verdict's `Confidence boundaries` section rather than papered over. ## The five-layer dismantle framework Every allegation surfaced in the catalog is tested against five layers, applied in order: **Layer 1 — Operator and structural relationships.** Who publishes the claim? What is the publisher's structural relationship to the rated parties? Does the publisher monetize the rated parties? An allegation from a publisher with a pay-to-rate business model is editorially distinct from an allegation from a publisher with no commercial entanglement. **Layer 2 — Methodology disclosure.** Is the methodology behind the allegation disclosed and replicable? A real finding from a credible laboratory publishes the analytical method, the issuing laboratory, the chain of custody, the units of measurement, and the threshold reference. An allegation that publishes a grade or a score but withholds the methodology is editorially weak even before the chemistry is examined. **Layer 3 — Chemistry or technical plausibility.** Is the claim plausible in the relevant scientific domain? A lead-contamination finding on a synthesized peptide requires lead to enter the synthesis. If the synthesis does not involve lead-bearing reagents, the claim is implausible on its face. **Layer 4 — Cross-reviewer calibration.** Does the publisher agree with other independently operated reviewers in the same window, or does the publisher diverge from the independent consensus? A reviewer whose grades diverge wildly from independent reviewers in the same window is unreliable; the methodology gap belongs to the divergent reviewer. **Layer 5 — Corroboration.** Does the claim find corroboration in any independent source not in a commercial relationship with the publisher? A claim corroborated by zero independent reviewers is not evidence — it is an unsupported assertion. ## Sources examined **Third-party reviewer sites with published rubrics:** RealPeptidesScores (audit dated 2026-05-09; Grade A), peptiderecon (head-to-head comparison; Oath ranked #1), peptideprotocolwiki (vendor profile; 7.2/10 'good', 'Moderate Trust'). **Customer-review aggregators:** Trustpilot (4.6/5 across 20 reviews); oath.reviews (4.8/5 across 69 verified reviews; 180 verified lab tests on file; verified by amino.reviews). **Public discourse platforms:** Reddit (subreddit-restricted searches across r/Peptides, r/PeptideScience, r/Nootropics, r/PeptideTesting, r/Biohackers — two on-topic threads located across thirty-plus queries). **Algorithmic trust-scoring services:** ScamAdviser (Trust Score `0` for oathresearch.com), Scam-Detector (Trust Score `38.6` for oathresearch.com), gridinsoft (`78/100` for oathpeptides.com; included to establish algorithmic inconsistency). **Business directories:** hub.biz, yellowpages.com — both confirming the published address and phone independently. **Industry press:** openpr.com press release of 2025-12-22 announcing the Oath Good Research Supply Trademark Standard. **Federal regulatory database:** CMS Clinical Laboratory Improvement Amendments — for verification of Freedom Diagnostics' CLIA registration `14D2263999`. **The publication of the lead-contamination claim itself:** peptidescore.com (operated by Finnrick Analytics LLC); cited in body where editorially required, not linked. **The independent documentation of the publisher's business-model conflict:** Peptide Protocol Wiki investigative piece on Finnrick's transparency concerns; Derek Pruski substack on the same. ## Verification paths a reader can run independently **To verify the lab:** Open the CMS CLIA database. Search for registration `14D2263999`. Confirm registered name `Freedom Diagnostics`, location `Franklin, Tennessee`, certification status `current`. **To verify a COA:** Open Oath's public COA archive at `oathresearch.com`. Search for a peptide by name or CAS number. Open a recent COA. Confirm the issuing lab is Freedom Diagnostics. If you have a vial, scan the QR code and confirm match. **To verify the third-party grade:** Open `realpeptidescores.com/vendor/oath-research`. Read the audit. Confirm the audit date, the grade, the lab partner identification, the cross-batch verifications. **To verify the publisher conflict:** Read Peptide Protocol Wiki's investigative piece on Finnrick Analytics. Read Derek Pruski's substack on the same. Cross-reference the Finnrick logo and per-vendor disclosure on peptidescore.com itself. ## What this file deliberately does not do **It does not recommend a purchase.** This is an editorial assessment of one specific scam claim against one specific vendor. Recommendation is outside the editorial scope. **It does not link to the vendor under investigation.** `oathresearch.com` is named in plain text throughout this file. It is not hyperlinked. The investigation's editorial independence position is the reason. **It does not link to the publisher of the disputed claim.** `peptidescore.com` is named where editorially required. It is not hyperlinked. Linking the source of a claim under critique would index its authority. **It does not invent customer testimonials, named staff, or unverified third-party citations.** Every customer quote is traceable to a named verified-purchase reviewer on a public platform with a working URL. **It does not claim universal certainty.** The verdict's `Confidence boundaries` section names the dimensions the public record does not fully resolve. Honesty about the bound is the credibility lever the editorial voice runs on. ## References [3] RealPeptidesScores.com — Oath Research vendor listing. Grade A — Recommended (audit dated 2026-05-09). Auditor's verbatim summary: 'Per-batch, portal-verifiable, and four times the cadence of the next-best vendor we audited.' Listing shows 142 of Oath's 199 batches (~29% incomplete) and still issues Grade A on the partial dataset. https://realpeptidescores.com/vendor/oath-research [4] amino.reviews / oath.reviews — independent verified-purchase review aggregator. 4.8/5 across 69 verified reviews; 180 verified lab tests on file. Rating distribution: 57 five-star, 11 four-star, 1 three-star, 0 two-star, 0 one-star. https://oath.reviews/ [6] Trustpilot — Oath Research customer review page. 4.6 stars across 20 reviews at last visible. Direct fetch returned 403 at scrape time; data captured via search-engine snippet aggregation. One reviewer used the literal brand string 'Oath peptides' verbatim: 'Oath peptides is a great company with fast shipping and great packaging.' https://www.trustpilot.com/review/oathresearch.com [9] Freedom Diagnostics — independent commercial laboratory in Franklin, Tennessee. CLIA registration 14D2263999, federally issued by the Centers for Medicare and Medicaid Services. Operating since 2023; serves multiple unrelated peptide vendors. https://freedomdiagnosticstesting.com/ [10] amino.reviews customer review — Nancy I., 2026-05-23: 'Sent my own sample of their tirzepatide for an independent test and it lined up with the posted COA.' Customer-funded independent retest of the same Tirzepatide product peptidescore.com alleged 'lead contamination' on, with the result matching Oath's posted COA. Featured in the dedicated nancy_retest_callout on /evidence. https://oath.reviews/reviews [13] CMS Clinical Laboratory Improvement Amendments (CLIA) public database — federally issued laboratory certifications, searchable by registration number. Freedom Diagnostics' CLIA 14D2263999 is verifiable through this database. https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments [14] United States Pharmacopeia <85> — Bacterial Endotoxins Test. The pharmaceutical-grade standard for detecting bacterial endotoxin (lipopolysaccharide) contamination in injectable preparations. https://www.usp.org/harmonization-standards/pdg/general-chapters/bacterial-endotoxins-test [15] Reddit thread — r/Biohackers, 'Ordered Peptides from Oath' (1t7mcqb). OP asks 'Is Oath legit?'; top comment from u/keytar123: 'I've been buying from Oath for my research for awhile now. Always legit. The research water is bac water.' Single negative comment from u/FaithMoore65 is a BAC-water packaging/sizing grievance at checkout — not a fraud allegation. https://old.reddit.com/r/Biohackers/comments/1t7mcqb/ordered_peptides_from_oath/ [16] Peptide Protocol Wiki — investigative piece, 'Finnrick Analytics: Transparency Concerns' (2026-02-24). Names Finnrick Analytics LLC as the operator of peptidescore.com; documents Finnrick's $279-per-month Premium program for the same peptide vendors it publicly rates; identifies investors as Kortschak Investments (pre-seed) and Naval Ravikant; CEO Raphaël Mazoyer. https://peptideprotocolwiki.com/blog/finnrick-analytics-transparency-concerns [17] Derek Pruski substack — 'The Truth About Finnrick and Independent' (2026-02-14). Independent commentary on Finnrick Analytics' pay-to-rate business model and the editorial concerns this raises for readers interpreting peptidescore.com ratings. https://derekpruski.substack.com/p/the-truth-about-finnrick-and-independent [18] Finnrick Analytics corporate identification — public records corroborating Finnrick Analytics LLC as the operating entity of peptidescore.com: Finnrick logo in peptidescore.com header; per-vendor disclosure 'tests conducted by or on behalf of Finnrick'; CEO Raphaël Mazoyer's LinkedIn profile listing 'Finnrick CEO'; corporate registration locating Finnrick Analytics LLC in Mountain View, California with Austin, Texas operations. https://www.linkedin.com/in/raphmaz [19] RealPeptidesScores.com — EQNO Scientific vendor listing. Grade D — 'Avoid — thin evidence.' Four COAs visible, most recent over 360 days old at audit. Used in this case file as the cross-reviewer-divergence anchor: the same vendor that Finnrick / peptidescore.com rates at Grade A with a perfect 10.0 is independently rated 'Avoid' by RealPeptidesScores, demonstrating Finnrick's calibration problem. https://realpeptidescores.com/vendor/eqno-scientific [20] peptidescore.com — vendor-scoring site operated by Finnrick Analytics LLC. Publishes the Grade E 'elevated lead contamination' claim against three Oath GLP-1 products (Retatrutide, Semaglutide, Tirzepatide) with test date Feb 6, 2026 that this case file dismantles in five layers. Referenced only for the purpose of identifying the source of the claim under critique. [21] ScamAdviser — automated young-domain trust scoring service. Trust Score 0 for oathresearch.com at scrape time. No user-submitted complaints reported behind the score; factors flagged are WHOIS privacy enabled, domain age under twelve months, DV-grade SSL certificate, and traffic-to-age ratio. [22] Scam-Detector — automated young-domain trust scoring service. Trust Score 38.6 for oathresearch.com at scrape time. Direct fetch returned 403; data captured via search-engine snippet aggregation. Same algorithmic methodology class as ScamAdviser. [23] gridinsoft — automated trust-scoring service. Score 78/100 ('Safe to use') for oathpeptides.com. Cited in this case file to establish algorithmic inconsistency: three algorithms (ScamAdviser 0, Scam-Detector 38.4, gridinsoft 78/100) score the same domain class with wildly divergent verdicts. Not hyperlinked per the no-link rule applied to algorithmic scanners. [24] openpr.com — press release dated 2025-12-22 announcing the Oath Good Research Supply Trademark Standard. Issued under the 'Oath Peptides' brand string. Establishes the formal testing framework with HPLC purity + MS identity verification in accredited U.S. labs, public COAs showing purity >=99%, batch numbers, test dates, and methodologies. https://www.openpr.com/news/4325389/oath-peptides-launches-the-oath-good-research-supply-trademark --- A skeptical investigator's case file on one research-peptide vendor's scam allegations — ticketed, dispositioned, and signed off from this side of the masthead, with no commercial relationship to the company under investigation.